Cronos Group Inc. (TSX-V: MJN) (OTC Nasdaq Int'l Designation: PRMCF) (the "Group" or the "Company") is pleased to announce the launch of Cronos Australia Pty Ltd. ("Cronos Australia") and the grant of medicinal cannabis cultivation and research licenses.
Cronos Group Inc. (TSXV: MJN) (OTC – Nasdaq Int'l Designation: PRMCF) ("Cronos Group" or the "Company") is pleased to announce that Peace Naturals Project Inc. ("Peace"), a licensed producer wholly owned by the Company, has just obtained a Dealer's License pursuant to the Controlled Drugs and Substances Act under Health Canada. This enables the Company to, through Peace, export medical cannabis extracts, including concentrated oil and resin products, internationally.
Cronos Group Inc. (TSX VENTURE: MJN)(OTC: PRMCF) is pleased to announce that it has entered into a letter of engagement with PI Financial Corp.
Canadian cannabis stocks were in rally mode yesterday and this comes after a strong rally by the U.S. market.
There are only two trading days left in 2017 and we are monitoring how the sector closes out the year. The month of December has been anything but slow and we have highlighted some of the most important developments during this time.
Aurora Is One Step Closer to Acquiring CanniMed
Cronos Group Inc. (TSX-V: MJN) (OTC – Nasdaq Int'l Designation: PRMCF) ("Cronos" or the "Company") is pleased to announce that its first shipment to G. Pohl-Boskamp GmbH & Co. KG ("Pohl-Boskamp") of Peace Naturals ("Peace") branded products is now available for sale across retail locations throughout Germany.
Cronos Group Inc. (TSX-V: MJN) (OTC Nasdaq International Designation: PRMCF) today reported financial results for the third quarter ended September 30, 2017. Financial results and the management discussion and analysis are available on the Company's website (www.thecronosgroup.com) and SEDAR (www.sedar.com).
Cronos Group Inc. (TSX-V: MJN) (OTC – Nasdaq Int'l Designation: PRMCF) ("Cronos" or the "Company") is pleased to announce that its previously announced strategic joint venture ("Cronos Israel") with Kibbutz Gan Shmuel ("Gan Shmuel") for the production, manufacture, and global distribution of medical cannabis, has been approved by the TSX Venture Exchange.
Canadian licensed medical marijuana producers were under pressure yesterday and we are monitoring how this trend continues today.
Although we have been favorable on this rally, we expressed some of our near-term concerns earlier this week as these stocks were trading at very overbought levels.
Following yesterday’s pullback, several medical marijuana producers under our coverage are no longer trading at overbought levels and we are favorable on this dip.
Cronos Group Inc. (TSXV:MJN) (OTC: PRMCF) is announcing today that it has entered into a commitment letter for $40 million in debt financing with Romspen Investment Corporation to fund the continued construction of its 315,000 sq. ft. expansion previously outlined in the Company's press release dated May 23, 2017.